Structure And Delivery For Patients With Cbt, Counselling, Medication Management, And The Community Reinforcement Approach

Also, I like it because many studies have shown that CBT treatment is very effective for many disorders such as depression, eating disorders, substance abuse, as well as anxiety disorders (Sheldon 2011). The treatment is very clear because it is based on the patient’s experience, it encourages practice and compliance, and the patients have a sense of control. Not only are the sessions collaborative, it empowers the patient by giving him an active role in the process. The treatment is relatively short too compared to other psychotherapy programs (Goldberg 2012). CBT is goal oriented too. Patients working with their therapists are asked to define goals for each session as well as long -term goals. Anyone with a mild or moderate depression can benefit from CBT.

Unlike OST, detoxification generally aims for opioid abstinence. Detoxification tends to be less successful than OST (Kleber, 2007). However, persons will seek this treatment for many reasons, such as a means to reduce costs associated with having an OUD. Some also choose to detox prior to entering a treatment program or before starting OST. Despite the fact that this approach is less effective, persons who undergo a complete detoxification relapse slower than those who dropout of detoxification. However, there are drugs that can be prescribed in order to prevent or delay relapse, as well as prevent withdrawal symptoms Examples of drugs that some patients will taper include methadone, buprenorphine, or clonidine (Kleber,

As previously discussed, the program the author would choose to evaluate is MAT treatment programs. This population consists of individuals that have been diagnosed with opiate use disorder, and receive opiate-substitution medications, such as Methadone or Suboxone. These program evaluations would be consumer-centered, performed in the clinics they receive services. Interested stakeholders would include the treatment center where the participants receive services, as well as other MAT service providers. Additionally, the funding sources for these individuals and program centers, such as county, state, and federal agencies, along with medical insurers, would also gain value from the program evaluation research.

Based on the participant’s background and history, I determined that an integrative approach using CBT and Reality Therapy was appropriate. Cognitive Behavior Therapy and Reality Therapy are both effective in treating addictions. My participant struggles with negative thinking and irrational thoughts, poor decision making and problem solving which are common for a person struggling with substance use disorders. Therefore, integrating these two treatment modalities will assist the participant in restructuring his thoughts and finding effective ways to bring about changes in his life by taking responsibility for his own actions.

The activity that I performed and relates to this outcome is medication reconciliation. I performed this activity in my IPPE-III class as a PS-III student. It was a mandatory activity, which I carried out in workshop in the group of 4 students. In this activity, we were given a patient case, which had list of all the medications that patient was taking and had patient’s demographic information. After reviewing patient’s given information, I had to interview a standardized patient and find out if the patient is taking all the medications as directed by prescriber or not. If patient is taking any other vitamins, herbal or OTC medications that is not on the list and also had to look out for if there is any discrepancy with the medications patient currently on for example, duplicate therapy, drug-drug interaction, incorrect frequency etc.

ESSENCE OF THE STORY: In the past few years, opioid addiction has become an epidemic in the United States leading to around 64,000 people dying from drug overdose in 2016 alone. As a result the health and human services secretary, Mr. Azar, and the F.D.A. chief, Dr. Scott Gottlieb, has made battling opioid addiction a top priority. The main way the F.D.A. is attempting to battle the epidemic is by allowing pharmaceutical companies to sell new types of medications that aren’t meant to stop addiction but to help suppress the cravings of addiction. The new medication that the F.D.A is approving is supposed to be a part of the program MAT, or medication-assisted-treatment. Mr. Azar as well as Dr. Scott have been pushing for more MAT in hope to help people with addiction live productive lives. Though like most big changes in society, the F.D.A’s decision has drawn criticism. Addiction experts are saying that new medication isn’t the solution but more access to the medication is.

Client was considered to be in semi-compliance with treatment during this reporting period. Client attended two secheduled groups with two absences. UA were negative for all tested substances. Client reported participating in self-help meeting regularly; verification was provided. Treatment attendance needs to be improved in 30 days.

In order to reduce the availability of inappropriately prescribed OPR, more care needs to be

Ross, S., Walker, A., & MacLeod, M. J. (2004). Patient compliance in hypertension: Role of illness perceptions and treatment beliefs. Journal of Human Hypertension, 18(9), 607-613. Retrieved from http://dx.doi.org/10.1038/sj.jhh.1001721

The Opioid Risk Tool (ORT) specifically identifies whether or not an individual has a family history of substance use, personal history of substance use or a psychological disorder. A second assessment is The Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R), this tool is typically self administered and consists of 24 questions. The SOAPP-R was designed to identify aberrant medication-related behaviors (Lakha, Louffat, Nicholson, Deshpande & Mailis-Gagnon, 2014). Finally, The Current Opioid Misuse Measure (COMM), a 17 question inventory, was also designed to measure the likelihood that the patient will misuse their prescribed medication. The SOAPP-R and the COMM were both designed to take an individual's pain scale into consideration during the assessment (Jamison, Serrailler & Michna,

Chakravarthy, B., Shah, S., & Lotfipour, S. (2012). Prescription drug monitoring programs and other interventions to combat prescription opioid abuse. Western Journal of Emergency Medicine. 13(5): 422-425.

Opioid Use Disorder (OUD) is a chronic and potentially life-threatening disease, and the main feature of which is addictive and compulsive opioid use (Drugs & Crime, 2010). Opioid drugs include some of the prescribed pain relievers as well as illicit drugs, such as heroin, codeine, oxycodone, etc. In the United States, about 9.5 million adults use pain relievers for nonmedical purpose, 1.6 million adults meet diagnostic criteria of pain reliever use disorders, and 0.56 million have heroin use disorder (Hedden, 2015), at a huge social and financial cost (Alan G. White et al., 2011). Furthermore, the relapse rate of OUD patients in treatment is high (Davstad et al., 2007).

Meditation has not been introduced as an intervention technique yet. I have not yet suggested the new intervention technique to my task supervisor or supervisor yet. After I make the suggestion I will need to first make sure meditation is a billable intervention technique for chemical and substance abuse. Ideally, I would like to begin implementing this intervention technique in January 2016 when I return from my Christmas break.

CBT is an integrated approach using various combinations of cognitive and behavioral modification interventions and techniques (Myers, 2005). The aim is to change maladaptive patterns of thinking and behaving that impact clients in the present (Weiten et al., 2009). From a cognitive behavioral perspective Jane would be diagnosed as having faulty thinking and dysfunctional behavioral issues suffering from depression, and anxiety in the form of Agoraphobia (Weiten et al., 2009).

The provision of written medication information given to the patient helps significantly in cases of medication non compliance (McGraw & Drennan 2004). This is because it aids in memory retention and presents patients with access to a reliable source of concise medication information, particularly if the patient needs to be reminded of certain aspects (Gorgos 2006). These written medication information sheets need to be provided in the patients primary, dominant language because it reduces the difficulty and limits barriers to patient understanding (Gorgos 2006).This is important because this intervention aims to increase a patient’s understanding of their medications, and when a patient feels more competent with the use of their medications, reduced